
Trustees establish life sciences research center
July 30, 2003
KALAMAZOO -- Acting during a special July 30 conference call
meeting, Western Michigan University trustees approved a recommendation
to launch a research center at WMU that will focus on the development
and commercialization of pharmaceutical and other bioscience
products, using $10 million in recently approved state funding.
The biosciences research and commercialization center at WMU
was established by unanimous vote of trustees. The resolution
authorized the establishment of the center and granted WMU President
Judith I. Bailey the authority to take all actions appropriate
to make the center a reality.
Pointing to the University's recent string of successes in
establishing the Business Technology and Research Park, securing
federal funding for its Nanotechnology Research and Computation
Center and licensing patented technology to a private firm for
development, Bailey said the board's action will give the University
the ability to move swiftly to take advantage of opportunities
and initiatives that will ensure the center's success.
"Working together, this University, the Kalamazoo community
and indeed all of Southwest Michigan and the state have a unique
opportunity to both dramatically enhance the rate of discovery
in the biosciences and ensure those discoveries meet with success
in the marketplace," Bailey said. "We're building a
center that will draw upon the scientific talent at the University
and in the community and merge it with this community's well-established
expertise and reputation for turning research into marketable
products."
Bailey noted the new WMU entity would be the only university
research center in the nation with a staff of pharmaceutical
commercialization experts. She expects that fact to lead to collaborative
work with other research centers in Michigan and beyond because
the WMU center will offer the expertise and mechanisms for taking
the discoveries of those other research centers from the laboratory
to the consumer market.
"This is one of very few places in the world that has
the pharmaceutical talent and infrastructure needed to make a
center like this work," Bailey said. "We also enjoy
intense community support and a level of commitment that will
ensure success."
The center will coordinate research activities and provide
an organizational home for scientists as they work to establish
new businesses, obtain extramural funding for research and develop
a center of excellence for pharmaceutical development to support
commercialization of the life sciences in Michigan. Activities
will be coordinated by a Life Sciences Consortium, consisting
of WMU and other educational and medical organizations, corporate
partners, economic developers and government entities.
University officials expect the center to become a model for
the efficient movement of discoveries from university research
laboratories to the market by providing access to the personnel
who have expertise in the final steps of the process.
Earlier this month, after intense efforts by local legislators
and University and community leadership, both houses of the Michigan
legislature approved supplemental funding of $10 million to be
used to launch a bioscience research and commercialization center
in Kalamazoo. The legislation is awaiting the signature of Gov.
Jennifer Granholm.
In a related matter, trustees approved a recommendation indicating
their support for having University officials explore the option
of establishing a research foundation at WMU. Any recommendation
to formally establish such an entity would be brought back to
the board for its consideration and action at a future meeting.
Separate research foundations are used by many universities
to support, fund and facilitate research activities and to focus
on developing and commercializing patents, technology and intellectual
property.
Media contact: Cheryl Roland, 269 387-8400, cheryl.roland@wmich.edu
|